Design of the Redefining Therapy in Early COPD Study.
Chronic obstructive pulmonary diseases (Miami, Fla.)
A randomised, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways.
The Journal of allergy and clinical immunology
RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative
Measured by units of improvement in SGRQ scores at Baseline and 12 weeks, as well as review of treatment failure status at 4 weeks and 12 weeks of treatment (treatment failure is defined by an increase in lower respiratory symptom...